Esperion (ESPR) announced that following meetings with the U.S. Food and Drug Administration, it has gained alignment on a regulatory path ...

Esperion Therapeutics (NASDAQ: ESPR) today announced it has entered into a license and distribution agreement with CSL Seqirus (ASX:CSL) for the exclusive rights to commercialize NEXLETOL ® (bempedoic ...

The Peace Research Institute Oslo (PRIO) conducts research on the conditions for peaceful relations between states, groups and people.

Use of cystatin C and SGLT2 inhibitors were highlighted in the Kidney Disease: Improving Global Outcomes (KDIGO) organization ...

I am 71, and I recently saw my urologist for urinating a lot and not getting enough sleep. He performed a flow test and a ...

Merck Data at ACC.25 Highlight Innovative Advancements and Commitment to Improving Outcomes for People Living with Cardiovascular Disease ...

After hours: March 19 at 4:38:17 PM EDT Loading Chart for NAMS ...

They appear to have a modest effect on boosting HDL (“good”) cholesterol as well. Ezetimibe (Zetia) is the first available treatment from this class of drugs. According to the American Heart ...

In OCEAN(a)-DOSE, most patients were already on other therapies, including statins, PCSK9 drugs, and cholesterol absorption inhibitor ezetimibe. "Epidemiological research has shown us that Lp(a ...

Improving Global Outcomes organization's updates to its 2024 guidelines expand SGLT2 inhibitor use and refine chronic kidney ...

Experts say everyone over 50 in the UK should be taking a daily pill that slashes cholesterol and blood pressure, and reduces the risk of heart attacks and strokes. The researchers say the pill could ...